Stockreport

Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024 [Yahoo! Finance]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Preclinical data support further development of IPH45, a differentiated topoisomerase I inhibitor ADC targeting Nectin-4, which is progressing towards the clinic MARS [Read more]